BLVRA and Parkinson disease: We found that both SMARCA4 (Table S3) and BLVRA (Table S4) harbor SNPs with meta‐analysis p value between 1E‐4 and 0.05, which can be regarded as the potential PD risk SNPs albeit not in the top 10,000 most significant GWAS results.